促销时间表 IDEAYA Biosciences, Inc.
先进的时间表
简单图表
关于公司 IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc., онкологическая компания, специализирующаяся на синтетической летальности, специализируется на открытии и разработке целевых терапевтических средств для групп пациентов, отобранных с помощью молекулярной диагностики. Продуктом-кандидатом компании является IDE196, ингибитор протеинкиназы C, который проходит фазу I / II клинических испытаний генетически определенных видов рака, имеющих мутации генов GNAQ или GNA11. 更多详情| IPO date | 2019-05-23 |
|---|---|
| ISIN | US45166A1025 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | http://www.ideayabio.com |
| Цена ао | 23.27 |
| 每日价格变化: | +1.42% (23.29) |
|---|---|
| 每周价格变化: | +6.49% (22.18) |
| 每月价格变化: | -6.64% (25.3) |
| 3个月内价格变化: | -19.39% (29.3) |
| 六个月内的价格变化: | -44.09% (42.25) |
| 每年价格变化: | -44.02% (42.19) |
| 3年内价格变化: | +38.13% (17.1) |
| 5年内价格变化: | +154.8% (9.27) |
| 10年价格变化: | 0% (23.62) |
| 年初以来价格变化: | -7.77% (25.61) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 交易日期 | 披露日期 | 内幕 | 类型 | 价格 | 体积 | 数量 | 分享最多, % | 之后分享, % | 文档 |
|---|---|---|---|---|---|---|---|---|---|
| 09.08.2023 | 11.08.2023 | Stone Paul A. Chief Financial Officer |
销售 | 25.05 | 62 625 | 2500 | 0 | -0.01 | 关联 |
| 09.08.2023 | 11.08.2023 | Throne Jason Chief Legal Officer |
销售 | 25.09 | 125 450 | 5000 | 0 | -0.01 | 关联 |
| 09.08.2023 | 11.08.2023 | Throne Jason Chief Legal Officer |
购买 | 13.34 | 66 700 | 5000 | 0 | 0.01 | 关联 |
| 10.07.2023 | 12.07.2023 | Throne Jason Chief Legal Officer |
销售 | 23 | 218 155 | 9485 | 0 | -0.02 | 关联 |
| 10.07.2023 | 12.07.2023 | Throne Jason Chief Legal Officer |
购买 | 10.09 | 95 704 | 9485 | 0 | 0.02 | 关联 |
| 06.07.2021 | 08.07.2021 | Throne Jason SVP, General Counsel |
销售 | 22.24 | 222 400 | 10000 | 0 | -0.05 | 关联 |
| 06.07.2021 | 08.07.2021 | Throne Jason SVP, General Counsel |
购买 | 8.52 | 85 200 | 10000 | 0 | 0.05 | 关联 |
| 06.07.2021 | 08.07.2021 | Dillon Michael P. SVP, Chief Scientific Officer |
销售 | 22.24 | 33 360 | 1500 | 0 | -0.01 | 关联 |
| 06.07.2021 | 08.07.2021 | Dillon Michael P. SVP, Chief Scientific Officer |
购买 | 6.92 | 10 380 | 1500 | 0 | 0.01 | 关联 |
| 机构 | 体积 | 分享, % |
|---|---|---|
| Blackrock Inc. | 5436668 | 7.29 |
| Federated Hermes, Inc. | 3883775 | 5.21 |
| Price (T.Rowe) Associates Inc | 3566278 | 4.78 |
| Janus Henderson Group PLC | 3551891 | 4.76 |
| Vanguard Group Inc | 3475772 | 4.66 |
| State Street Corporation | 2991899 | 4.01 |
| Adage Capital Partners GP L.L.C. | 2925094 | 3.92 |
| Canaan Partners X LLC | 2660713 | 3.57 |
| Deerfield Management Company, L.P. (Series C) | 2630292 | 3.53 |
| Boxer Capital, LLC | 2202812 | 2.95 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Mr. Yujiro S. Hata | President, CEO & Director | 851.7k | 1974 (51 年) |
| Dr. Paul A. Barsanti Ph.D. | Chief Technology Officer | N/A | |
| Mr. Andres Ruiz Briseno CPA | Principal Accounting Officer, Senior VP and Head of Finance & Investor Relations | N/A | 1986 (39 年) |
| Dr. Michael A. White Ph.D. | Chief Scientific Officer | 613.85k | 1966 (59 年) |
| Dr. Darrin M. Beaupre M.D., Ph.D. | Chief Medical Officer | 152.64k | 1967 (58 年) |
| Ms. Francine Zelaya | Vice President & Head of Human Resources | ||
| Mr. Mick O'Quigley | Chief of Staff & Clinical Development | ||
| Mr. Daniel A. Simon | Chief Business Officer | ||
| Mr. Douglas B. Snyder | Senior VP & General Counsel | 1964 (61 年) |
地址: United States, South San Francisco, CA , 7000 Shoreline Court - 在 Google 地图中打开, 打开 Yandex 地图
网站: http://www.ideayabio.com
网站: http://www.ideayabio.com
